There are errors present in the values presented in [Table 5](#pone.0199075.t001){ref-type="table"}. [Table 5](#pone.0199075.t001){ref-type="table"} shows the observed probability. The corrected version of [Table 5](#pone.0199075.t001){ref-type="table"} now shows the estimated probability. The development and validation of the models is presented in Tables 2--4 and Figs 1--2 and these aspects of the work stand unaffected. The final \"tool\" that clinicians would be using is [Table 5](#pone.0199075.t001){ref-type="table"} to show the predicted probability that their patient with a given score will develop diabetes over the next 3 years. This is the culmination of the modeling work and has been reported incorrectly in the original publication. Please see the corrected [Table 5](#pone.0199075.t001){ref-type="table"} here.
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###### Total point for each risk score and absolute estimated probability (%) of incidence of type 2 diabetes.
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  Non-invasive model   Model including FPG   Model including HbA1c   Model including FPG and HbA1c                    
  -------------------- --------------------- ----------------------- ------------------------------- ---- ------ ---- ------
  0                    0.5                   0                       0.2                             0    0.1    0    0.1
  2                    0.9                   1                       0.2                             1    0.1    1    0.1
  3                    1.1                   2                       0.4                             2    0.2    2    0.1
  4                    1.5                   3                       0.6                             3    0.2    3    0.2
  5                    1.9                   4                       1.0                             4    0.4    4    0.3
  6                    2.5                   5                       1.6                             5    0.6    5    0.5
  7                    3.2                   6                       2.5                             6    1.0    6    0.7
  8                    4.2                   7                       3.9                             7    1.6    7    1.1
  9                    5.4                   8                       6.1                             8    2.4    8    1.7
  10                   7.0                   9                       9.4                             9    3.8    9    2.5
  11                   9.0                   10                      14.2                            10   6.0    10   3.9
  12                   11.5                  11                      21.0                            11   9.2    11   5.8
  13                   14.5                  12                      29.8                            12   13.9   12   8.6
  14                   18.2                  13                      40.4                            13   20.4   13   12.6
  15                   22.6                  14                      52.0                            14   28.9   14   18.1
  16                   27.7                  15                      63.4                            15   39.3   15   25.4
                                                                                                                 16   34.3
                                                                                                                 17   44.4
                                                                                                                 18   55.1
                                                                                                                 19   65.3
                                                                                                                 20   74.2

Abbreviation: FPG, fasting plasma glucose.

The twenty-sixth author's name appears incorrectly. The correct name is: Huanhuan Hu.

There are several text errors throughout the article. The errors and corrections are as follows:

The last line of the Results paragraph of the Abstract section should read: Participants with a noninvasive score of ≥15 and invasive score of ≥ 18 were projected to have \>20% and \>50% risk, respectively, of developing type 2 diabetes within 3 years.

The last two lines of the sixth paragraph of the Results section should read: In the invasive model including both FPG and HbA1c, participants with a score of 0 to 10 (77.4% of total participants), 11 to 12 (10.5%), 13 to 14 (6.9%), and 15 to 17 (5.0%) had less than 5%, 5 to \<10%, 10 to \<20%, and 20 to \<50% risk of incident type 2 diabetes, respectively. Those with a score of ≥18 (0.2% of total participants) had \>50% risk.

There are errors in the figure caption for [Fig 1](#pone.0199075.g001){ref-type="fig"}. Please see the correct [Fig 1](#pone.0199075.g001){ref-type="fig"} caption here.

![Receiver operating characteristics (ROC) curves for each risk score model in predicting type 2 diabetes.\
Abbreviation: FPG, fasting plasma glucose. In the derivation cohort, the area under the ROC (95% confidence interval) were 0.717 (0.703--0.731) for the non-invasive model, 0.843 (0.832--0.853) for the model including FPG, 0.827 (0.816--0.838) for the model including HbA1c, and 0.893 (0.883--0.902) for the model including both FPG and HbA1c. In the validation cohort, the corresponding value were 0.734 (0.715--0.753) for the non-invasive model, 0.835 (0.820--0.851) for the model including FPG, 0.819 (0.803--0.835) for the model including HbA1c, and 0.882 (0.868--0.895) for the model including both FPG and HbA1c.](pone.0199075.g001){#pone.0199075.g001}
